Studies

Heinzl N, Ghezelayagh TS, Wang G, Kohrn BF, Katz R, Coombes C, Smith TH, Norgaard ZK, Lo FY, Schmidt EK, Higgins JE, Valentine CC, Filipits M, Romanens L, Labidi-Galy I, Postl M, Grimm C, Cibula D, Dostálek L, Frühauf F, Jelenek G, Plch M, Fabian P, Mustea A, Condic M, Pristauz-Telsnigg G, Tamussino K, Bouda J, Brambs CE, O'Toole S et al. (2026)
High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage
NPJ Precis Oncol, 10 (1)
DOI 10.1038/s41698-026-01657-x, PubMed 42686803

Rosnes Gissum K, Engen C, Drageset S, Zahl Eriksson AG, Vistad I, Strand R, Bjørge L (2026)
Hope and hopelessness in the face of ovarian cancer: perspectives from gynecologists
Front Oncol, 16, 1931795
DOI 10.3389/fonc.2026.1931795, PubMed 42656476

Plante M, Kwon JS, Mahner S, Cormier B, Fortin S, Theret P, Bats AS, de Kroon C, Van Driel W, Tidy J, Williamson K, Hillemanns P, Goffin F, Polterauer S, Eyjolfsdottir B, Maguire PJ, Kim SI, Atri M, Shepherd L, Tu D (2026)
Correlation of pelvic magnetic resonance imaging with diagnostic loop electrosurgical excision procedure/cone biopsy and hysterectomy pathology: an exploratory analysis of the CX.5/SHAPE trial
Int J Gynecol Cancer, 36 (9), 104835
DOI 10.1016/j.ijgc.2026.104835, PubMed 42520498